Akerman Group Focuses On Medical Marijuana

, Daily Business Review

   | 1 Comments

Akerman launched a regulated substances task force to assist clients with proposed changes in laws governing regulated substances, including medical marijuana.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • Stephen Marcellus

    I wonder if law firms doing cannabis law in states like Colorado, California, and Washington are planning to come into Florida to take advantage of our legalizing cannabis here. And if they do, how will they fare when they are new to the state but have years of experience over the local firms. I‘m expecting a knock-down drag out fight.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202654017803

Thank you!

This article's comments will be reviewed.